AMD 2020 Q3 Form 10-Q Summary
Business context and reporting period
Advanced Micro Devices, Inc. is a global semiconductor company offering client and server CPUs, GPUs, APUs, chipsets, embedded processors, semi-custom SoCs, development services and intellectual-property licensing. The filing covers the three and nine months ended September 26, 2020, compared with September 28, 2019. Each period comprised 13 and 39 weeks, respectively. Results are unaudited and prepared under U.S. GAAP.
Financial performance and liquidity
| Metric | Q3 2020 | Q3 2019 | 9M 2020 | 9M 2019 |
|---|---|---|---|---|
| Revenue | $2.801 billion | $1.801 billion | $6.519 billion | $4.604 billion |
| Gross profit | $1.230 billion | $777 million | $2.896 billion | $1.919 billion |
| Gross margin | 44% | 43% | 44% | 42% |
| Operating income | $449 million | $186 million | $799 million | $283 million |
| Net income | $390 million | $120 million | $709 million | $171 million |
| Diluted EPS | $0.32 | $0.11 | $0.59 | $0.15 |
- Q3 revenue increased 56%; nine-month revenue increased 42%.
- Computing and Graphics revenue rose 31% in Q3 and 47% for the nine-month period. Q3 unit shipments increased 44%, while average selling price declined 7%, primarily because of Radeon product-cycle timing.
- Enterprise, Embedded and Semi-Custom revenue increased 116% in Q3 and 31% year to date, driven by higher semi-custom and EPYC server processor sales in Q3.
- Gross margin improved primarily from higher-margin Ryzen and EPYC processor sales, partly offset by lower-margin semi-custom products.
- Research and development expense increased 25% in Q3 to $508 million; marketing, general and administrative expense increased 48% to $273 million.
- Nine-month operating cash flow was $517 million, compared with $51 million in the prior-year period. Capital expenditures were $220 million.
- Cash, cash equivalents and short-term investments totaled approximately $1.8 billion at September 26, 2020, including $1.296 billion of cash and cash equivalents and $475 million of short-term investments.
- Total debt principal declined to $398 million from $563 million at December 28, 2019. Long-term debt, net, was $373 million.
- AMD had a $500 million revolving credit facility, with $13 million of letters of credit outstanding and no borrowings at quarter-end. Management stated that available liquidity and the facility should fund operations and capital expenditures for the next 12 months.
Material changes versus the prior comparable period
- Profitability expanded substantially as revenue growth more than offset higher operating expenses. Q3 operating income increased to $449 million from $186 million, and net income increased to $390 million from $120 million.
- Computing and Graphics operating income increased to $384 million from $179 million in Q3 and to $846 million from $217 million for the first nine months.
- Enterprise, Embedded and Semi-Custom operating income increased to $141 million from $61 million in Q3. Nine-month operating income declined to $148 million from $218 million because the prior-year period included a $60 million licensing gain and current expenses were higher.
- Interest expense declined to $11 million in Q3 and $38 million for nine months, primarily because of lower debt balances.
- AMD converted $165 million principal amount of its 2.125% convertible notes into approximately 20 million common shares and recorded a $38 million loss related to the conversions. The remaining $86 million principal amount was convertible at the holder’s option beginning October 1, 2020.
- Accounts receivable increased to $2.134 billion and inventories to $1.292 billion from $1.859 billion and $982 million, respectively, at year-end 2019, reflecting higher revenue and product builds.
Guidance, outlook, commentary and risks
- The filing does not provide a clear numerical revenue or earnings forecast for the remainder of 2020. Management noted that results are seasonal and historically tend to be higher in the second half of the year.
- Management reported limited financial disruption from COVID-19 during Q3 but expects the pandemic to continue affecting operations, supply chains, employee practices, demand and customer payments.
- AMD entered into an agreement on October 26, 2020 to acquire Xilinx in an all-stock transaction valued at approximately $35 billion at signing. Xilinx shareholders would receive 1.7234 AMD shares per Xilinx share. Closing is subject to shareholder and regulatory approvals and is expected by the end of calendar year 2021.
- Key disclosed risks include intense competition from Intel, Nvidia and other companies; reliance on third-party wafer foundries and assembly, testing and packaging suppliers; manufacturing capacity and yield constraints; dependence on a limited number of customers; product-cycle and semiconductor-industry cyclicality; inventory obsolescence and pricing pressure; international operations and U.S.-China trade restrictions; cybersecurity and product vulnerabilities; and risks associated with completing and integrating Xilinx.
- Substantially all U.S. and foreign deferred tax assets remained subject to valuation allowances. Management stated that continued improvement could eventually support release of a significant portion of those allowances, creating a material non-cash tax benefit, but no release was recorded in the period.
- Remaining performance obligations totaled $375 million at quarter-end, of which $178 million was expected to be recognized over the next 12 months.
- Reported legal matters included shareholder derivative litigation, a Monterey Research patent case and a shareholder complaint filed in September 2020. Management stated that currently known potential liabilities were not expected to have a material adverse effect.
Important facts for investors to verify
- Verify whether Ryzen, EPYC and semi-custom demand continues to support revenue growth and gross-margin expansion, particularly as product mix changes.
- Monitor conversion of the remaining convertible notes, potential share dilution and the effect of the approximately 20 million shares already issued in conversions.
- Assess working-capital trends, especially the increases in accounts receivable and inventories relative to operating cash flow.
- Track third-party foundry and packaging capacity, wafer purchase commitments with GLOBALFOUNDRIES, and the ability to meet demand for 7nm products.
- Evaluate the timing, regulatory conditions, financing implications, dilution and integration risks of the proposed Xilinx acquisition.
- Review the potential effects of COVID-19, U.S.-China trade restrictions, Entity List requirements and international supply-chain disruptions.
- Monitor deferred-tax-asset valuation allowances, uncertain tax benefits of $84 million, and any future tax benefit from allowance releases.